Open Access381 HIGHER CARDIOVASCULAR RISK AND IMPAIRED BENEFIT OF ANTIHYPERTENSIVE TREATMENT IN HYPERTENSIVE PATIENTS REQUIRING ADDITIONAL DRUGS ON TOP OF RANDOMIZED THERAPY. IS ADDING DRUGS ALWAYS BENEFICIAL?
Author(s) -
Yuqing Zhang,
Xuezhong Zhang,
Lisheng Liu,
Yan Wang,
Xiaonan Tang,
Alberto Zanchetti
Publication year - 2012
Publication title -
journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.249
H-Index - 172
eISSN - 1473-5598
pISSN - 0263-6352
DOI - 10.1097/01.hjh.0000420230.75866.d4
Subject(s) - medicine , felodipine , randomized controlled trial , placebo , confounding , incidence (geometry) , population , blood pressure , physics , alternative medicine , environmental health , pathology , optics